Here are four things to know.
1. Dr. Fitzgerald’s resignation came less than 48 hours after Politico published a report revealing she invested in tobacco and drug company stock while leading the CDC.
2. CDC COO Sherri Berger sent an agencywide email naming Ms. Schuchat acting director just three hours after news of Dr. Fitzgerald’s resignation went public, according to The Washington Post.
3. Dr. Schuchat has served as the agency’s principal deputy director since September 2015. She also previously served as acting CDC director from January 2017, when President Donald Trump took office, to July 2017, when he appointed Dr. Fitzgerald to the role.
4. Dr. Schuchat joined the CDC in 1988, where she’s overseen the agency’s vaccine and bacteria prevention programs, among other initiatives.
More articles on leadership and management:
ACA repeal and replace not discussed during Trump’s State of the Union
Mike Harbour: 5 actions leaders can take to decrease physician burnout
6 healthcare trends for leaders to follow in 2018
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
